Enzymatic biodegradation of poly(ethylene oxide-b-ε-caprolactone) diblock copolymer and its potential biomedical applications

被引:167
作者
Gan, ZH
Jim, TF
Li, M
Yuer, Z
Wang, SG
Wu, C [1 ]
机构
[1] Chinese Univ Hong Kong, Dept Chem, Shatin, NT, Peoples R China
[2] Univ Sci & Technol China, Dept Chem Phys, Open Lab Bone Select Chem, Hefei 230026, Anhui, Peoples R China
[3] Chinese Acad Sci, Inst Chem, Lab Membranes & Med Polymers, Beijing 100080, Peoples R China
关键词
D O I
10.1021/ma981121a
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
Water-insoluble poly(ethylene oxide-b-epsilon-caprolactone)(PEO-b-PCL) diblock copolymer (M-w = 1.71 x 10(4) g/mol and W-PEO = 20%) was successfully micronized into small polymeric core-shell nanoparticles (micelles) stable in water via a microphase inversion method. Such formed PEO-b-PCL nanoparticles are biodegradable in the presence of Lipase PS (enzyme). The biodegradation of the PEO-b-PCL nanoparticles, actually, only the hydrophobic PCL core, was monitored by laser Light scattering. The biodegradation extent could he influenced by both the copolymer and enzyme concentrations, while the biodegradation rate was mainly determined by the enzyme concentration. Using pyrene as an imitative drug and fluorescence spectroscopy, we have shown that hydrophobic drugs can be easily loaded into the PCL core in the micronization process, and the biodegradation of the PCL block results in the dissolution of the nanoparticles and the releasing of pyrene molecules because the PEO block is soluble in water. The potential biomedical application of the PEO-b-PCL nanoparticles as a controlled release device has been demonstrated.
引用
收藏
页码:590 / 594
页数:5
相关论文
共 33 条
[1]   Amphiphilic copolymers and their applications [J].
Alexandridis, P .
CURRENT OPINION IN COLLOID & INTERFACE SCIENCE, 1996, 1 (04) :490-501
[2]  
ALLEMANN E, 1993, EUR J PHARM BIOPHARM, V39, P13
[3]  
[Anonymous], INT J PHARM
[4]  
Berne B.J., 2000, DOVER BOOKS PHYS SER
[5]   Optimized preparation of poly D,L (lactic-glycolic) microspheres and nanoparticles for oral administration [J].
Chacon, M ;
Berges, L ;
Molpeceres, J ;
Aberturas, MR ;
Guzman, M .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 141 (1-2) :81-91
[6]   Synthesis and characterization of amphiphilic poly(ethylene glycol) graft copolymers and their potential application as drug carriers [J].
Chiu, HC ;
Chern, CS ;
Lee, CK ;
Chang, HF .
POLYMER, 1998, 39 (8-9) :1609-1616
[7]   STRUCTURE AND DYNAMICS OF BLOCK-COPOLYMER COLLOIDS [J].
CHU, B .
LANGMUIR, 1995, 11 (02) :414-421
[8]  
Chu B., 1991, LASER LIGHT SCATTERI, V2nd
[9]   EFFECT OF EXCLUDED VOLUME ON POLYMER DISPERSANT ACTION [J].
DOLAN, AK ;
EDWARDS, SF .
PROCEEDINGS OF THE ROYAL SOCIETY OF LONDON SERIES A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES, 1975, 343 (1635) :427-442
[10]   NANOCAPSULE FORMATION BY INTERFACIAL POLYMER DEPOSITION FOLLOWING SOLVENT DISPLACEMENT [J].
FESSI, H ;
PUISIEUX, F ;
DEVISSAGUET, JP ;
AMMOURY, N ;
BENITA, S .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 55 (01) :R1-R4